178 related articles for article (PubMed ID: 36870293)
1. Cigarette Smoke Enhances the Malignant Phenotype of Esophageal Adenocarcinoma Cells by Disrupting a Repressive Regulatory Interaction Between miR-145 and LOXL2.
Xi S; Oyetunji S; Wang H; Azoury S; Liu Y; Hsiao SH; Zhang M; Carr SR; Hoang CD; Chen H; Schrump DS
Lab Invest; 2023 Apr; 103(4):100014. PubMed ID: 36870293
[TBL] [Abstract][Full Text] [Related]
2. Cigarette smoke mediates epigenetic repression of miR-217 during esophageal adenocarcinogenesis.
Xi S; Inchauste S; Guo H; Shan J; Xiao Z; Xu H; Miettenen M; Zhang MR; Hong JA; Raiji MT; Altorki NK; Casson AG; Beer DG; Robles AI; Bowman ED; Harris CC; Steinberg SM; Schrump DS
Oncogene; 2015 Oct; 34(44):5548-59. PubMed ID: 25703328
[TBL] [Abstract][Full Text] [Related]
3. Cigarette smoke mediates epigenetic repression of miR-487b during pulmonary carcinogenesis.
Xi S; Xu H; Shan J; Tao Y; Hong JA; Inchauste S; Zhang M; Kunst TF; Mercedes L; Schrump DS
J Clin Invest; 2013 Mar; 123(3):1241-61. PubMed ID: 23426183
[TBL] [Abstract][Full Text] [Related]
4. Bile acid and cigarette smoke enhance the aggressive phenotype of esophageal adenocarcinoma cells by downregulation of the mitochondrial uncoupling protein-2.
Xu Y; Feingold PL; Surman DR; Brown K; Xi S; Davis JL; Hernandez J; Schrump DS; Ripley RT
Oncotarget; 2017 Nov; 8(60):101057-101071. PubMed ID: 29254145
[TBL] [Abstract][Full Text] [Related]
5. Mithramycin represses basal and cigarette smoke-induced expression of ABCG2 and inhibits stem cell signaling in lung and esophageal cancer cells.
Zhang M; Mathur A; Zhang Y; Xi S; Atay S; Hong JA; Datrice N; Upham T; Kemp CD; Ripley RT; Wiegand G; Avital I; Fetsch P; Mani H; Zlott D; Robey R; Bates SE; Li X; Rao M; Schrump DS
Cancer Res; 2012 Aug; 72(16):4178-92. PubMed ID: 22751465
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-17 is downregulated in esophageal adenocarcinoma cancer stem-like cells and promotes a radioresistant phenotype.
Lynam-Lennon N; Heavey S; Sommerville G; Bibby BA; Ffrench B; Quinn J; Gasch C; O'Leary JJ; Gallagher MF; Reynolds JV; Maher SG
Oncotarget; 2017 Feb; 8(7):11400-11413. PubMed ID: 28002789
[TBL] [Abstract][Full Text] [Related]
7. MicroRNAs in Barrett's esophagus and esophageal adenocarcinoma.
Kan T; Meltzer SJ
Curr Opin Pharmacol; 2009 Dec; 9(6):727-32. PubMed ID: 19773200
[TBL] [Abstract][Full Text] [Related]
8. Cigarette smoke induces C/EBP-β-mediated activation of miR-31 in normal human respiratory epithelia and lung cancer cells.
Xi S; Yang M; Tao Y; Xu H; Shan J; Inchauste S; Zhang M; Mercedes L; Hong JA; Rao M; Schrump DS
PLoS One; 2010 Oct; 5(10):e13764. PubMed ID: 21048943
[TBL] [Abstract][Full Text] [Related]
9. microRNAs: Key regulators of chemotherapy response and metastatic potential via complex control of target pathways in esophageal adenocarcinoma.
Matuszcak C; Lindner K; Eichelmann AK; Hussey DJ; Haier J; Hummel R
Surg Oncol; 2018 Sep; 27(3):392-401. PubMed ID: 30217293
[TBL] [Abstract][Full Text] [Related]
10. Dynamic changes in microRNA expression profiles reflect progression of Barrett's esophagus to esophageal adenocarcinoma.
Slaby O; Srovnal J; Radova L; Gregar J; Juracek J; Luzna P; Svoboda M; Hajduch M; Ehrmann J
Carcinogenesis; 2015 May; 36(5):521-7. PubMed ID: 25784377
[TBL] [Abstract][Full Text] [Related]
11. SOX4 interacts with EZH2 and HDAC3 to suppress microRNA-31 in invasive esophageal cancer cells.
Koumangoye RB; Andl T; Taubenslag KJ; Zilberman ST; Taylor CJ; Loomans HA; Andl CD
Mol Cancer; 2015 Feb; 14():24. PubMed ID: 25644061
[TBL] [Abstract][Full Text] [Related]
12. A Systematic Review of Esophageal MicroRNA Markers for Diagnosis and Monitoring of Barrett's Esophagus.
Mallick R; Patnaik SK; Wani S; Bansal A
Dig Dis Sci; 2016 Apr; 61(4):1039-50. PubMed ID: 26572780
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA 223 is upregulated in the multistep progression of Barrett's esophagus and modulates sensitivity to chemotherapy by targeting PARP1.
Streppel MM; Pai S; Campbell NR; Hu C; Yabuuchi S; Canto MI; Wang JS; Montgomery EA; Maitra A
Clin Cancer Res; 2013 Aug; 19(15):4067-78. PubMed ID: 23757351
[TBL] [Abstract][Full Text] [Related]
14. The miR-106b-25 polycistron, activated by genomic amplification, functions as an oncogene by suppressing p21 and Bim.
Kan T; Sato F; Ito T; Matsumura N; David S; Cheng Y; Agarwal R; Paun BC; Jin Z; Olaru AV; Selaru FM; Hamilton JP; Yang J; Abraham JM; Mori Y; Meltzer SJ
Gastroenterology; 2009 May; 136(5):1689-700. PubMed ID: 19422085
[TBL] [Abstract][Full Text] [Related]
15. Esophageal squamous cell carcinoma cell proliferation induced by exposure to low concentration of cigarette smoke extract is mediated via targeting miR-101-3p/COX-2 pathway.
Gong J; Chu Y; Xu M; Huo J; Lv L
Oncol Rep; 2016 Jan; 35(1):463-71. PubMed ID: 26530100
[TBL] [Abstract][Full Text] [Related]
16. Deciphering the unique microRNA signature in human esophageal adenocarcinoma.
Saad R; Chen Z; Zhu S; Jia P; Zhao Z; Washington MK; Belkhiri A; El-Rifai W
PLoS One; 2013; 8(5):e64463. PubMed ID: 23724052
[TBL] [Abstract][Full Text] [Related]
17. Esophageal Adenocarcinoma-Derived Extracellular Vesicle MicroRNAs Induce a Neoplastic Phenotype in Gastric Organoids.
Ke X; Yan R; Sun Z; Cheng Y; Meltzer A; Lu N; Shu X; Wang Z; Huang B; Liu X; Wang Z; Song JH; Ng CK; Ibrahim S; Abraham JM; Shin EJ; He S; Meltzer SJ
Neoplasia; 2017 Nov; 19(11):941-949. PubMed ID: 28968550
[TBL] [Abstract][Full Text] [Related]
18. Esophageal pepsin and proton pump synthesis in barrett's esophagus and esophageal adenocarcinoma.
Samuels TL; Altman KW; Gould JC; Kindel T; Bosler M; MacKinnon A; Hagen CE; Johnston N
Laryngoscope; 2019 Dec; 129(12):2687-2695. PubMed ID: 31046139
[TBL] [Abstract][Full Text] [Related]
19. MicroRNAs in Esophageal Adenocarcinoma: Functional Significance and Potential for the Development of New Molecular Disease Markers.
Bobryshev YV; Orekhov AN; Chistiakov DA
Curr Pharm Des; 2015; 21(23):3402-16. PubMed ID: 25758856
[TBL] [Abstract][Full Text] [Related]
20. miR-200 family expression is downregulated upon neoplastic progression of Barrett's esophagus.
Smith CM; Watson DI; Leong MP; Mayne GC; Michael MZ; Wijnhoven BP; Hussey DJ
World J Gastroenterol; 2011 Feb; 17(8):1036-44. PubMed ID: 21448356
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
